253 related articles for article (PubMed ID: 31272268)
21. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study.
Xu XJ; Zhang YL; Liu L; Pan L; Yao SK
Aliment Pharmacol Ther; 2017 Jan; 45(1):100-114. PubMed ID: 27862119
[TBL] [Abstract][Full Text] [Related]
22. Oridonin Alleviates Visceral Hyperalgesia in a Rat Model of Postinflammatory Irritable Bowel Syndrome: Role of Colonic Enterochromaffin Cell and Serotonin Availability.
Zang KH; Shao YY; Zuo X; Rao Z; Qin HY
J Med Food; 2016 Jun; 19(6):586-92. PubMed ID: 27111743
[TBL] [Abstract][Full Text] [Related]
23. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome.
Willot S; Gauthier C; Patey N; Faure C
Neurogastroenterol Motil; 2012 Aug; 24(8):734-9, e347. PubMed ID: 22625872
[TBL] [Abstract][Full Text] [Related]
24. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
[TBL] [Abstract][Full Text] [Related]
25. Nerve growth factor-mediated neuronal plasticity in spinal cord contributes to neonatal maternal separation-induced visceral hypersensitivity in rats.
Tsang SW; Zhao M; Wu J; Sung JJ; Bian ZX
Eur J Pain; 2012 Apr; 16(4):463-72. PubMed ID: 22396076
[TBL] [Abstract][Full Text] [Related]
26. CRF1 receptors as a therapeutic target for irritable bowel syndrome.
Martinez V; Taché Y
Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612
[TBL] [Abstract][Full Text] [Related]
27. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract.
Gershon MD
Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):14-21. PubMed ID: 23222853
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?
Xu XJ; Liu L; Yao SK
J Zhejiang Univ Sci B; 2016 Jan; 17(1):1-9. PubMed ID: 26739521
[TBL] [Abstract][Full Text] [Related]
29. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.
Crowell MD; Shetzline MA; Moses PL; Mawe GM; Talley NJ
Curr Opin Investig Drugs; 2004 Jan; 5(1):55-60. PubMed ID: 14983974
[TBL] [Abstract][Full Text] [Related]
30. The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling.
Yu Y; Wu S; Li J; Wang R; Xie X; Yu X; Pan J; Xu Y; Zheng L
Metab Brain Dis; 2015 Feb; 30(1):47-55. PubMed ID: 24807589
[TBL] [Abstract][Full Text] [Related]
31. Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats.
Barreau F; Salvador-Cartier C; Houdeau E; Bueno L; Fioramonti J
Gut; 2008 May; 57(5):582-90. PubMed ID: 18194988
[TBL] [Abstract][Full Text] [Related]
32. The 5-HT
Hagbom M; Hellysaz A; Istrate C; Nordgren J; Sharma S; de-Faria FM; Magnusson KE; Svensson L
J Virol; 2021 Jul; 95(15):e0075121. PubMed ID: 33980599
[TBL] [Abstract][Full Text] [Related]
33. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome.
Gershon MD
J Clin Gastroenterol; 2005; 39(5 Suppl 3):S184-93. PubMed ID: 15798484
[TBL] [Abstract][Full Text] [Related]
34. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
[TBL] [Abstract][Full Text] [Related]
35. Visceral hyperalgesia induced by neonatal maternal separation is associated with nerve growth factor-mediated central neuronal plasticity in rat spinal cord.
Chung EK; Zhang XJ; Xu HX; Sung JJ; Bian ZX
Neuroscience; 2007 Nov; 149(3):685-95. PubMed ID: 17913374
[TBL] [Abstract][Full Text] [Related]
36. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
Gershon MD
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
[TBL] [Abstract][Full Text] [Related]
37. Costunolide ameliorates intestinal dysfunction and depressive behaviour in mice with stress-induced irritable bowel syndrome
Li X; Liu Q; Yu J; Zhang R; Sun T; Jiang W; Hu N; Yang P; Luo L; Ren J; Wang Q; Wang Y; Yang Q
Food Funct; 2021 May; 12(9):4142-4151. PubMed ID: 33977961
[TBL] [Abstract][Full Text] [Related]
38. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
Moskwa A; Boznańska P
Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
[TBL] [Abstract][Full Text] [Related]
39. New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments.
Crowell MD; Harris L; Jones MP; Chang L
Curr Gastroenterol Rep; 2005 Aug; 7(4):272-9. PubMed ID: 16042910
[TBL] [Abstract][Full Text] [Related]
40. Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome.
Ren TH; Wu J; Yew D; Ziea E; Lao L; Leung WK; Berman B; Hu PJ; Sung JJ
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G849-56. PubMed ID: 17110521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
